Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment
- PMID: 21494034
- PMCID: PMC3085034
- DOI: 10.1159/000324711
Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment
Abstract
Background: In Alzheimer's disease, neurodegenerative atrophy progresses from the entorhinal cortex (ERC) to the hippocampus (HP), limbic system and neocortex. The significance of very mild atrophy of the ERC and HP on MRI scans among elderly subjects is unknown.
Methods: A validated visual rating system on coronal MRI scans was used to identify no atrophy of the HP or ERC (HP(0); ERC(0)), or minimal atrophy of the HP or ERC (HP(ma); ERC(ma)), among 414 participants. Subjects fell into the following groups: (1) ERC(0)/HP(0), (2) ERC(ma)/HP(0), (3) ERC(0)/HP(ma), and (4) ERC(ma)/HP(ma). HP volume was independently measured using volumetric methods.
Results: In comparison to ERC(0)/HP(0) subjects, those with ERC(0)/HP(ma) had impairment on 1 memory test, ERC(ma)/HP(0) subjects had impairment on 2 memory tests and the Mini Mental State Examination (MMSE), while ERC(ma)/HP(ma) subjects had impairment on 3 memory tests, the MMSE and Clinical Dementia Rating. Progression rates of cognitive and functional impairment were significantly greater among subjects with ERC(ma).
Conclusion: Minimal atrophy of the ERC results in greater impairment than minimal atrophy of the HP, and the combination is additive when measured by cognitive and functional tests. Rates of progression to greater impairment were higher among ERC(ma) subjects.
Copyright © 2011 S. Karger AG, Basel.
Figures


Similar articles
-
Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.Int J Geriatr Psychiatry. 2015 Feb;30(2):192-200. doi: 10.1002/gps.4126. Epub 2014 May 12. Int J Geriatr Psychiatry. 2015. PMID: 24816477
-
Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.J Alzheimers Dis. 2013;33(3):755-66. doi: 10.3233/JAD-2012-121408. J Alzheimers Dis. 2013. PMID: 23047370
-
Higher atrophy rate of entorhinal cortex than hippocampus in AD.Neurology. 2004 Feb 10;62(3):422-7. doi: 10.1212/01.wnl.0000106462.72282.90. Neurology. 2004. PMID: 14872024 Free PMC article.
-
Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia.Mov Disord. 2012 May;27(6):727-34. doi: 10.1002/mds.24938. Epub 2012 Mar 12. Mov Disord. 2012. PMID: 22410753 Free PMC article.
-
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease.J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):441-7. doi: 10.1136/jnnp.71.4.441. J Neurol Neurosurg Psychiatry. 2001. PMID: 11561025 Free PMC article.
Cited by
-
Study Design and Baseline Results in a Cohort Study to Identify Predictors for the Clinical Progression to Mild Cognitive Impairment or Dementia From Subjective Cognitive Decline (CoSCo) Study.Dement Neurocogn Disord. 2022 Oct;21(4):147-161. doi: 10.12779/dnd.2022.21.4.147. Epub 2022 Oct 31. Dement Neurocogn Disord. 2022. PMID: 36407288 Free PMC article.
-
Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults.Neuroimage Clin. 2019;22:101769. doi: 10.1016/j.nicl.2019.101769. Epub 2019 Mar 11. Neuroimage Clin. 2019. PMID: 30927602 Free PMC article.
-
Sex-Specific Entorhinal Cortex Functional Connectivity in Cognitively Normal Older Adults with Amyloid-β Pathology.Mol Neurobiol. 2025 Jan;62(1):475-484. doi: 10.1007/s12035-024-04243-z. Epub 2024 Jun 13. Mol Neurobiol. 2025. PMID: 38867110 Free PMC article.
-
Two Alzheimer's disease risk genes increase entorhinal cortex volume in young adults.Front Hum Neurosci. 2014 Oct 6;8:779. doi: 10.3389/fnhum.2014.00779. eCollection 2014. Front Hum Neurosci. 2014. PMID: 25339884 Free PMC article.
-
Examining the relationship between anxiety and regional brain volumes in the National Alzheimer's Coordinating Center uniform, imaging, and biomarker datasets.Cereb Circ Cogn Behav. 2024 Jan 16;6:100201. doi: 10.1016/j.cccb.2024.100201. eCollection 2024. Cereb Circ Cogn Behav. 2024. PMID: 38312309 Free PMC article.
References
-
- Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A. Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol. 2002;59:1729–1734. - PubMed
-
- Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad KB, Blennow CSF Biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302:385–393. - PubMed
-
- Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–319. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous